Filing Details
- Accession Number:
- 0001140361-18-043653
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-11-26 13:39:56
- Reporting Period:
- 2018-11-21
- Accepted Time:
- 2018-11-26 13:39:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1398733 | Aquestive Therapeutics Inc. | AQST | Pharmaceutical Preparations (2834) | 208623253 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1739025 | T. John Maxwell | C/O Aquestive Therapeutics, Inc. 30 Technology Drive Warren NJ 07059 | Svp-Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-11-21 | 10,000 | $9.80 | 148,614 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Includes 10,000 shares owned jointly with Mr. Maxwell's spouse.
Billionaire Hedge Funds
